CLINICAL_TRIALS
safety_alert
· 2017-03-27
Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.
Summary
Safety surveillance is underway to monitor potential early liver injuries associated with Xianlin Gubao Capsule. The update highlights concerns for drug-induced…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing 302 Hospital | Conditions: Drug-Induced Liver Injury | Status: UNKNOWN